MOXAFRICA

+ 44 (0)121 421 3480

info@moxafrica.org

103 Chestnut Road
Oldbury, West Midlands - B68 0AY
UK

  • White Instagram Icon
  • White YouTube Icon
  • White Facebook Icon

@2019 by Moxafrica

Welcome to

MOXAFRICA IS A BRITISH CHARITY TO INVESTIGATE DIRECT MOXIBUSTION IMMUNOMODULATION AS AN ADJUNCTIVE TREATMENT FOR TUBERCULOSIS.

MOXAFRICA

DIRECT

MOXIBUSTION

Small cone direct moxibustion (‘moxa’) consists of smouldering rice-grain sized cones of moxa (refined Artemesia Princeps) on specific locations on the skin. This therapy has been used in conjunction with acupuncture (as well as in a stand-alone treatment) in East Asian Medicine for centuries. Techniques weres particularly refined and developed in Japan.

 

Moxa is known to have positive effects on blood circulation and also to enhance the immune system. Small cone direct moxibustion also has a history which significantly includes documentary evidence of treating and curing patients with TB.

 

Moxa is extremely low-tech, is safe and is also very cheap. It is also eminently adaptable to resource-poor and remote environments.

 

Given all of the above we are carrying out investigative research to establish whether moxibustion can help combat TB today. 

ABOUT

TUBERCULOSIS

Tuberculosis (TB) is a disease caused by a bacterial infection and is transmitted through the air when someone who is infectious with the disease coughs or sneezes. TB is both preventable and treatable with special antibiotics, yet every year it kills more people than any other infectious disease. In fact in 2016 more people died from TB than HIV and malaria combined.

 

Treating this disease is complicated because the bacteria possesses an unusually thick, waxy cell wall which isn’t easy for drugs to penetrate and because it also has the ability to survive in multiple locations in the body. It also has the unusual capacity to ‘hide out’ in the body for years following the first infection – a condition which is called ‘latent infection’.

Because the bacteria are so hardy it means that even straightforward treatment of standard ‘drug-susceptible’ TB needs a combination of four different drugs taken for at least six months. With drug-resistant it needs six drugs with pernicious and often permanent side-effects for between 9 and 24 months with very poor treatment outcomes.

Help us continue our work including supporting the important research in North Korea, helping develop new projects in Gujerat (India) and Angola, and fostering a coherent investigative agenda into Field Medicine

PROJECTS

Moxafrica has completed the only scientific study looking at the effects of moxa on TB and HIV today. We are now developing further research into the effects of moxa on the immune system in North Korea. We are also helping develop moxa projects wherever we can. Our aim is to help empower people to help themselves with home therapy that really helps their health and recovery from illness.

UGANDA

Makerere University's School of Health Sciences

SOUTH

AFRICA

Moxa project in Nyanga

NORTH

KOREA

The NEW Project

RESULTS OF RESEARCH

RCT PHASE II (Randomised Control Trial)

Conducted by Makerere University's School of Health Sciences, Uganda.

THE STUDY IS COMPLETED!

The data analysed and manuscript is in the final stages of completion for submission to a peer-reviewed journal.